Simris Group AB (PUBL) (FRA:5LU)

Market Cap	10.60M +38.3%
Revenue (ttm)	171.33K -25.7%
Net Income	-2.46M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0028
Previous Close	0.0024
Day's Range	0.0028 - 0.0028
52-Week Range	0.0002 - 0.0186
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About Simris Group AB (PUBL)

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2011
• Employees: 5
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5LU

Financial Performance

In 2025, Simris Group AB (PUBL)'s revenue was 1.62 million, a decrease of -44.12% compared to the previous year's 2.89 million. Losses were -26.81 million, -22.52% less than in 2024.

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error